Immunity to avian influenza A viruses

OIE Revue Scientifique et Technique

Volumn 28, Issue 1, 2009, Pages 175-185

  Doherty, P C ^a,b   Brown, L E ^a   Kelso, A ^c   Thomas, R G ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

Antibody; Cytokine shock; Cytotoxicity; Memory; Protection; Secondary response; T cell

Indexed keywords

AVES; INFLUENZA A VIRUS; INFLUENZAVIRUS A; MUS; ORTHOMYXOVIRIDAE; VERTEBRATA;

EID: 68149166540     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.28.1.1857     Document Type: Article

References (102)

1. Ambrose C.S., Yi T., Walker R.E. & Connor E.M. (2008) - Duration of protection provided by live attenuated influenza vaccine in children. Pediatr. infect. Dis. J., 27(8), 744-748.
2. Baras B., Stittelaar K.J., Simon J.H., Thoolen R.J., Mossman S.P., Pistoor EH., van Amerongen G., Wettendorff M.A., Hanon E. & Osterhaus A.D. (2008). - Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS ONE, 3(1), el401.
3. Belz G.T., Wodarz D., Diaz G., Nowak M.A. & Doherty EC. (2002). - Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J. Virol., 76(23), 12388-12393.
4. Bennett S.R., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F. & Heath W.R. (1998). - Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature, 393 (6684), 478-480.
5. Bessa J., Schmitz N., Hinton H.J., Schwarz K., Jegerlehner A. & Bachmann M.F. (2008). - Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design. Eur. J. Immunol., 38(1), 114-126.
6. Block S.L., Yogev R., Hayden F.G., Ambrose C.S., Zeng W. & Walker R.E. (2008). - Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Vaccine, 26(38), 4940-4946.
7. Boyman O., Ramsey C., Kim D.M., Sprent J. & Surh C.D. (2008). - IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T cell expansion without lymphopenia. J. Immunol., 180(11), 7265-7275.
8. Bright R.A., Carter D.M., Crevar C.J., Toapanta F.R., Steckbeck J.D., Cole K.S., Kumar N.M., Pushko P., Smith G., Tumpey T.M. & Ross T.M. (2008). - Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE, 3(1), el501.
9. Brown D.M., Dilzer A.M., Meents D.L. & Swain S.L. (2006). - CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol., 177(5), 2888-2898.
10. Brown D.M., Roman E. & Swain S.L. (2004). - CD4 T cell responses to influenza infection. Semin. Immunol., 16(3), 171-177.
11. Brown L.E. & Jackson D.C. (2005). - Lipid-based selfadjuvanting vaccines. Curr. Drug Deliv., 2(4), 383-393.
12. Budd A., Alleva L., Alsharifi M., Koskinen A., Smythe V., Mullbacher A., Wood J. & Clark I. (2007). - Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob. Agents Chemother., 51(8), 2965-2968.
13. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I. & Lanzavecchia A. (1999). - Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. experimen. Med., 189(5), 821-829.
14. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., Gordon S., Guan Y. & Peiris J.S. (2002). - Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease Lancet, 360 (9348), 1831-1837.
15. Cox M.M. (2005). - Cell-based protein vaccines for influenza. Curr. Opin. mol. Ther., 7(1), 24-29.
16. Cox R.J., Haaheim L.R., Ericsson J.C., Madhun A.S. & Brokstad K.A. (2006). - The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man. Vaccine, 24 (44-46), 6577-6580.
17. Crowe S.R., Miller S.C., Brown D.M., Adams P.S., Dutton R.W., Harmsen A.G., Lund F.E., Randall T.D., Swain S.L. & Woodland D.L. (2006). - Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine, 24(4), 457-467.
18. + T cells efficiently in cancer patients. J. Immunother., 29(5), 499-511.
19. De Jong J.C., Palache A.M., Beyer WE., Rimmelzwaan G.F., Boon A.C. & Osterhaus A.D. (2003). - Haemagglutinationinhibiting antibody to influenza virus. Dev. Biol. (Basel), 115, 63-73.
20. + T cells for long-term pulmonary protection against influenza. Eur. J. Immunol., 36(3), 770-778.
21. Demkowicz WE. Jr, Littaua R.A., Wang J. & Ennis EA. (1996). - Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol., 70(4), 2627-2631.
22. Denis J., Acosta-Ramirez E., Zhao Y., Hamelin M.E., Koukavica I., Baz M., Abed Y., Savard C., Pare C., Lopez Macias C., Boivin G. & Leclerc D. (2008). - Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine, 26 (27-28), 3395-3403.
23. Depla E., Van der Aa A., Livingston B.D., Crimi C., Allosery K., De Brabandere V., Krakover J., Murthy S. et al. (2008). - Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections. J. Virol., 82(1), 435-450.
24. Doherty P.C. & Kelso A. (2008). - Toward a broadly protective influenza vaccine. J. clin. Invest., 118(10), 3273-3275.
25. Doherty P.C., Turner S.J., Webby R.G. & Thomas P.G. (2006). - Influenza and the challenge for immunology. Nat. Immun., 7(5), 449-455.
26. D'Onise K. & Raupach J.C. (2008). - The burden of influenza in healthy children in South Australia. Med. J. Aust., 188(9), 510-513.
27. + T cells in the lung airways retain the potential to mediate recall responses. J. Immunol., 171(7), 3338-3342.
28. Fedson D.S. (2008). - Confronting an influenza pandemic with inexpensive generic agents: can it be done Lancet infect. Dis., 8(9), 571-576.
29. Fiers W., De Filette M., Birkett A., Neirynck S. & Min Jou W. (2004). - A "universal" human influenza A vaccine. Virus Res., 103 (1-2), 173-176.
30. Flynn K.J., Riberdy J.M., Christensen J.P., Altman J.D. & Doherty P.C. (1999). - In vivo proliferation of naive and memory influenza-specific CD8(+) T cells. Proc. natl Acad. Sci. USA, 96(15), 8597-8602.
31. - but not plasmacytoid dendritic cells. J. experim. Med., 205(7), 1621-1634.
32. Govorkova E.A., Rehg J.E., Krauss S., Yen H.L., Guan Y., Peiris M., Nguyen T.D., Hanh T.H. et al. (2005). - Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol., 79(4), 2191-2198.
33. Graham M.B., Dalton D.K., Giltinan D., Braciale V.L., Stewart T.A. & Braciale T.J. (1993). - Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J. experim. Med., 178(5), 1725-1732.
34. He X.S., Holmes T.H., Zhang C., Mahmood K., Kemble G.W., Lewis D.B., Dekker C.L., Greenberg H.B. & Arvin A.M. (2006). - Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J. Virol., 80(23), 11756-11766.
35. Heinen P.P., Rijsewijk F.A., de Boer-Luijtze E.A. & Bianchi A.T. (2002). - Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J. gen. Virol., 83 (Pt 8), 1851-1859.
36. Ho L.P., Denney L., Luhn K., Teoh D., Clelland C. & McMichael A.J. (2008). - Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. Eur. J. Immunol., 38(7), 1913-1922.
37. Hoffmann E., Lipatov A.S., Webby R.J., Govorkova E.A. & Webster R.G. (2005). - Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc. natl Acad. Sci. USA, 102(36), 12915-12920.
38. + T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol., 166(3), 1813-1822.
39. Huleatt J.W., Nakaar V., Desai P., Huang Y., Hewitt D., Jacobs A., Tang J., McDonald W. et al. (2008). - Potent immunogemcity and efficacy of a universal influenza vaccine candidate compnsing a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine, 26(2), 201-214.
40. + T cells. J. Immunol., 181(6), 3818-3822.
41. Jennings L.C., Monto A.S., Chan P.K., Szucs T.D. & Nicholson K.G. (2008). - Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet infect. Dis., 8(10), 650-658.
42. + T cells in influenza virusinfected mice. Proc. natl Acad. Sci. USA, 100(5), 2657-2662.
43. Joo H.M., He Y. & Sangster M.Y. (2008). - Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia. Proc. natl Acad. Sci. USA, 105(9), 3485-3490.
44. + T-cell memory in a model of localized transient infection. Immunol. Rev., 211, 133-145.
45. + T cell memory. Proc. natl Acad. Sci. USA, 104(23), 9782-9787.
46. Keeler C.L., Jr., Bliss T.W., Lavric M. & Maughan M.N. (2007). - A functional genomics approach to the study of avian innate immunity. Cytogenet. Genome Res., 117 (1-4), 139-145.
47. Ko S.Y., Ko H.J., Chang W.S., Park S.H., Kweon M.N. & Kang C.Y. (2005). - Alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J. Immunol., 175(5), 3309-3317.
48. Kobasa D., Jones S.M., Shinya K., Kash J.C., Copps J., Ebihara H., Hatta Y., Kim J.H. et al. (2007). - Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature, 445 (7125), 319-323.
49. Kong K.F., Delroux K., Wang X., Qian F., Arjona A., Malawista S.E., Fikrig E. & Montgomery R.R. (2008). - Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J. Virol., 82(15), 7613-7623.
50. Kreijtz J.H., de Mutsert G., van Baalen C.A., Fouchier R.A., Osterhaus A.D. & Rimmelzwaan G.F. (2008). - Crossrecognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol., 82(11), 5161-5166.
51. + T cell responses: correlation of cytokine profile and TCR avidity. J. Immunol., 172(9), 5553-5560.
52. Lalor P.A., Webby R.J., Morrow J., Rusalov D., Kaslow D.C., Rolland A. & Smith L.R. (2008). - Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. J. infect. Dis., 197(12), 1643-1652.
53. Lee L.Y., Ha D.L., Simmons C., de Jong M.D., Chau N.V., Schumacher R., Peng Y.C., McMichael A.J. et al. (2008). - Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. clin. Invest., 118(10), 3478-3490.
54. Lipatov A.S., Andreansky S., Webby R.J., Hulse D.J., Rehg J.E., Krauss S., Perez D.R., Doherty P.C., Webster R.G. & Sangster M.Y., (2005). - Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B-and T-cell responses. J. gen. Virol., (Pt 4), 1121-1130.
55. McElhaney J.E. & Dutz J.P. (2008). - Better influenza vaccines for older people: what will it take J. infect. Dis., 198(5), 632-634.
56. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.F. & Bleackley R.C. (2006). - T cell responses are better correlates of vaccine protection in the elderly. J. Immunol., 176(10), 6333-6339.
57. McMichael A.J., Gotch EM., Dongworth D.W., Clark A. & Potter C.W. (1983). - Declining T-cell immunity to influenza, 1977-82. Lancet, 2 (8353), 762-764.
58. McMichael A.J., Gotch F.M., Noble G.R. & Beare P.A. (1983). - Cytotoxic T-cell immunity to influenza. N. Engl. J. Med., 309(1), 13-17.
59. Mames T.R., Szretter K.J., Perrone L., Belser J.A., Bright R.A., Zeng H., Tumpey T.M. & Katz J.M. (2008). - Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol. Rev., 225(1), 68-84.
60. + T cells after viral stimulation PLoS ONE, 3(2), el691.
61. Moyron-Quiroz J.E., Rangel-Moreno J., Kusser K., Hartson L., Sprague F., Goodrich S., Woodland D.L., Lund F.E. & Randall T.D. (2004). - Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med., 10(9), 927-934.
62. Mozdzanowska K., Feng J., Eid M., Kragol G., Cudic M., Otvos L., Jr. & Gerhard W. (2003). - Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomams of matrix protein 2. Vaccine, 21 (19-20), 2616-2626.
63. New Scientist (2008). - Commentary. New Scientist, 197 (2638).
64. Ochi A., Danesh A., Seneviratne C., Banner D., Devries M.E., Rowe T., Xu L., Ran L. et al. (2008). - Cloning, expression and immunoassay detection of ferret IFN-gamma. Dev. Comp. Immunol., 32(8), 890-897.
65. Omar A.R. & Schat K.A. (1997). - Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology, 90(4), 579-585.
66. Ostler T., Hussell T., Surh C.D., Openshaw P. & Ehl S. (2001). - Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus. Eur. J. Immunol., 31(9), 2574-2582.
67. Pantin-Jackwood M.J. & Swayne D.E. (2009). - The pathogenesis and pathobiology of avian influenza virus infection in birds. In Avian influenza (T.C. Mettenleiter, ed.). Rev. sci. tech. Off. int. Epiz., 28(1), 113-136.
68. Peiris M. (2006). - Pathogenesis of avian flu H5N1 and SARS. Novartis Found. Symp., 279, 56-60; discussion 60-65,216-219.
69. Perrone L.A., Plowden J.K., Garcia-Sastre A. Katz J.M. & Tumpey T.M. (2008). - H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog., 4(8), e1000115.
70. Powell T.J., Strutt T., Reome J., Hollenbaugh J.A., Roberts A.D., Woodland D.L., Swain S.L. & Dutton R.W. (2007). - Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus. J. Immunol., 178(2), 1030-1038.
71. + memory T cells are IL-15 dependent. J. experim. Med., 204(4), 951-961.
72. Reese S., Dalamani G. & Kaspers B. (2006). - The avian lungassociated immune system: a review. Vet. Res., 37(3), 311-324.
73. Reiner S.L. (2008). - Inducing the T cell fates required for immunity. Immunol Res., 42 (1-3), 160-165.
74. Riberdy J.M., Flynn K.J., Stech J., Webster R.G., Altman J.D. & Doherty P.C. (1999). - Protection against a lethal avian influenza A virus in a mammalian system. J. Virol., 73(2), 1453-1459.
75. + T-helper and a T-killer cell. Nature, 393 (6684), 474-478.
76. Rimmelzwaan G.F., Boon A.C., Voeten J.T., Berkhoff E.G., Fouchier R.A. & Osterhaus A.D. (2004). - Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. Virus. Res., 103 (1-2), 97-100.
77. Rutigliano J.A., Doherty P.C., Franks J., Morris M.Y., Reynolds C. & Thomas P.G. (2008). - Screening monoclonal antibodies for cross-reactivity in the ferret model of influenza infection. J. Immunol Meth., 336(1), 71-77.
78. Salomon R., Hoffmann E. & Webster R.G. (2007). - Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. natl Acad. Sci. USA, 104(30), 12479-12481.
79. Salomon R., Staeheli P., Kochs G., Yen H.L., Franks J., Rehg J.E., Webster R.G. & Hoffmann E. (2007). - Mxl gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle, 6(19), 2417-2421.
80. + T celldependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J. experim. Med., 198(7), 1011-1021.
81. Seo S.H. & Webster R.G. (2001). - Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J. Virol., 75(6), 2516-2525.
82. Swayne D.E. & Kapczynski D. (2008). - Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev., 225(1), 314-331.
83. Szretter K.J., Gangappa S., Lu X., Smith C., Shieh W.J., Zaki S.R., Sambhara S., Tumpey T.M. & Katz J.M. (2007). - Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol., 81(6), 2736-2744.
84. Targonski P.V., Jacobson R.M. & Poland G.A. (2007). - Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine, 25(16), 3066-3069.
85. Thitithanyanont A., Engering A., Ekchariyawat P., Wiboon-ut S., Limsalakpetch A., Yongvanitchit K., Kum-Arb U., Kanchongkittiphon W. et al. (2007). - High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J. Immunol., 179(8), 5220-5227.
86. Thomas P.G., Keating R., Hulse-Post D.J. & Doherty P.C. (2006). - Cell-mediated protection in influenza infection. Emerg. infect. Dis., 12(1), 48-54.
87. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., Hogan R.J., Wu Z., Benton K.A., Tumpey T.M. & Epstein S.L. (2007). - Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg. infect. Dis., 13(3), 426-435.
88. + T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol., 159(11), 5197-5200.
89. Tripp R.A. & Tompkins S.M. (2008). - Recombinant vaccines for influenza virus. Curr. Opin. investig. Drugs, 9(8), 836-845.
90. Tripp R.A., Topham D. J., Watson S.R. & Doherty P.C. (1997). - Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. J. Immunol., 158(8), 3716-3720.
91. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Pantin-Jackwood M.J., Schultz-Cherry S., Solorzano A. et al. (2005). - Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol., 79(23), 14933-14944.
92. + T cell response. Immunity, 18(4), 549-559.
93. Turner S.J., Kedzierska K., Komodromou H., La Gruta N.L., Dunstone M.A., Webb A.I., Webby R., Walden H. et al. (2005). - Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8(+) T cell populations. Nat. Immunol., 6(4), 382-389.
94. + effector T cells. Proc. natl Acad. Sci. USA, 101(10), 3545-3550.
95. Van Duin D. & Shaw A.C. (2007). - Toll-like receptors in older adults. J. Am. Geriatr. Soc., 55(9), 1438-1444.
96. Wang S.K., Liang P.H., Astronomo R.D., Hsu T.L., Hsieh S.L., Burton D.R. & Wong C.H. (2008). - Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN. Proc. natl Acad. Sci. USA, 105(10), 3690-3695.
97. Webby R.J. & Sandbulte M.R. (2008). - Influenza vaccines. Front. Biosci., 13, 4912-4924.
98. Wiley J.A., Tighe M.P. & Harmsen A.G. (2005). - Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes. J. Immunol., 175(5), 3186-3196.
99. Wrammert J. & Ahmed R., (2008). - Maintenance of serological memory. Bioi. Chem., 389(5), 537-539.
100. Yager E.J., Ahmed M., Lanzer K., Randall T.D., Woodland D.L. & Blackman M.A. (2008). - Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J. experim. Med., 205(3), 711-723.
101. Yu X., Tsibane T., McGraw P.A., House F.S., Keefer C.J., Hicar M.D., Tumpey T.M., Pappas C. et al. (2008). - Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature, 455 (7212), 532-536.
102. Zammit D.J., Turner D.L., Klonowski K.D., Lefrancois L. & Cauley L.S. (2006). - Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity, 24(4), 439-449.